Fundamentals

Valuation

Metric	Q1	Q3	Δ in %
EV/EBITDA	-98.08	-162.83	8477.65
Graham Fair Price	44.09	2.12	1.47
PEG	-74.02	0.08	0.31
Price/Book	-14.32	5.56	6.49
Price/Cash Flow	-737.18	-53.42	-6.38
Prices/Earnings	47.92	-12.50	-24.01
Price/Sales	-25.64	2.11	2.84
Price/FCF	-737.18	-53.42	-6.38
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q3	Δ in %
Gross Profit Margin	-48.60	0.03	0.06
Operating Margin	-138.68	-0.04	-0.02
ROA	-71.84	< 0.005	< 0.005
ROE	-0.07	-0.11	-64.51
ROIC	< 0.005	-0.02	-194.46
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q3	Δ in %
Debt QOQ	-0.17	< 0.005	-4075.29
Dividends QOQ	-0.68	-0.23	66.52
EBIT QOQ	0.79	0.46	-41.18
EPS QOQ	0.78	-1.56	100.43
FCF QOQ	-0.83	-1.45	-75.15
Revenue QOQ	-0.20	0.36	76.25
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	183.77	153.78	-16.32
Days Sales Outstanding (DSO)	54.87	24.45	-55.44
Inventory Turnover	0.49	0.59	19.50
Debt/Capitalization	0.87	0.86	-1.04
Quick Ratio	0.37	0.46	23.37
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q3	Δ in %
Book Value	1.19	4.61	286.35
Cash	1.15	1.87	62.65
Capex	-0.31	0.31	-0.69
Free Cash Flow	-1.21	-0.14	88.50
Revenue	2.73	3.53	29.45
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q3	Δ in %
Current Ratio	1.16	1.16	0.24
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	3843.95	-72.96	-98.10
Naive Interpretation	Member

06 - Financial Health · Bad

Rating